The definitive directory of biotech venture capital and investment firms, spanning crossover and public-market funds, corporate venture arms, early-stage and seed VCs, global and European funds, growth equity, and company-creation firms. Curated for founders raising rounds, business development leads tracking capital, and LPs mapping managers.
BioMed Nexus tracks 147 biotech venture capital and investment firms across 7 categories: crossover & public, corporate VC, early stage & seed, global & EU, growth equity, multi-stage, and company creation. The directory covers the leading biotech investors, including Flagship Pioneering, ARCH Venture Partners, OrbiMed, Third Rock, RA Capital and Novo Holdings, alongside emerging funds. Last updated July 2026
Every listing here is free by name. Add a Verified Listing ($495 per year) with a tagline, website link, and verified badge, or go Featured for your logo, full description, and priority placement at the top of this directory. Data Partners also get a dedicated landing page and a sponsored spotlight in a daily brief reaching about 43,000 recipients.
Featured spots are limited per category.
Right now, every firm in this directory is just a name in a database. Featured partners get a full profile with logo, investment focus, portfolio highlights, backlinks, and priority placement at the very top of this page. Claim the top spot before your competitors do. A Verified Listing is the lighter option: your tagline, website link, and verified badge for $495 per year.
The BioMed Nexus Biotech Venture Capital & Investors Directory is a comprehensive, regularly updated list of investors funding the life sciences, spanning crossover and public-market funds, corporate venture capital arms of pharma companies, early-stage and seed VCs, global and European funds, growth equity firms, multi-stage generalists, and company-creation firms. It covers the most active biotech investors alongside emerging funds.
Use it to research biotech investors by stage and strategy, shortlist funding partners, and map the venture landscape. Whether you are a founder raising a round, a business development lead tracking capital, or an LP mapping managers, the directory provides structured, current firm data. Curated and maintained by the BioMed Nexus editorial team; last updated July 2026.
Firms can claim a free listing by name or add a Verified Listing ($495 per year) with a tagline, website link, and verified badge. Featured Profiles and Data Partners get priority placement, and Data Partners add a dedicated landing page and a sponsored spotlight in the BioMed Nexus daily brief, which reaches about 43,000 recipients per weekday edition. Contact our partnerships team to learn more.
